logo

For the Inventor, By the Inventor

Fujishiro, Japan

Takahiro Nakazawa

This inventor holds 5 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 1985-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Nakazawa. Retrieved from https://idiyas.com/inventor/takahiro-nakazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 9.6

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Fujishiro, JP (1987 - 1990)
  • Fujishiromachi, JP (1985 - 1996)

Company Filing History:

goldMedal5 out of 677 
 
Eisai Company, Limited
 patents

Years Active: 1985-1996

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5523307 - Cyclic amine and pharmacological composition (1996-06-04),
2. 5196439 - Piperidine compounds useful to treat cerebrovascular diseases (1993-03-23),
3. 4921863 - Cyclic amine derivatives (1990-05-01),
4. 4707468 - Polypeptide (1987-11-17),
5. 4551273 - Analgesic peptide and process for the preparation thereof (1985-11-05),

Title: The Innovations of Takahiro Nakazawa

Introduction

Takahiro Nakazawa is a prominent inventor based in Fujishiro, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of cyclic amines and their applications in treating cerebrovascular diseases. With a total of 5 patents to his name, Nakazawa's work is recognized for its potential impact on mental health treatments.

Latest Patents

Among his latest patents, Nakazawa has developed a cyclic amine defined by a specific formula, which includes components such as naphthyl, phenyl, and alkyl. This cyclic amine is particularly useful in treating mental symptoms associated with cerebrovascular diseases. Another notable patent involves piperidine compounds that also target cerebrovascular diseases, showcasing his focus on innovative solutions for complex health issues.

Career Highlights

Takahiro Nakazawa is currently associated with Eisai Company, Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment options for patients suffering from cerebrovascular conditions.

Collaborations

Nakazawa collaborates with talented coworkers, including Takeru Kaneko and Kiyomi Yamatsu. Their combined expertise contributes to the innovative environment at Eisai Company, Limited, fostering advancements in pharmacological research.

Conclusion

Takahiro Nakazawa's contributions to the field of pharmacology through his innovative patents highlight his commitment to improving mental health treatments. His work continues to pave the way for new therapeutic options in addressing cerebrovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…